TrialBone marrow transplantation2012

A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up.

K A Kasow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.